Elevated low-density lipoprotein cholesterol (LDL-C) enhances proerectile neurotransmission in the corpus cavernosum

被引:5
|
作者
Srilatha, B [1 ]
Adaikan, PG [1 ]
Ng, SC [1 ]
Arulkumaran, S [1 ]
机构
[1] Natl Univ Singapore, Natl Univ Singapore Hosp, Dept Obstet & Gynaecol, Singapore 119074, Singapore
关键词
hypercholesterolaemia; nitrergic transmission; corpus cavernosum; impotence;
D O I
10.1038/sj.ijir.3900403
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Hypercholesterolaemia is thought to foster atherosclerosis and impotence through its effects on vascular endothelium. In this study, we investigated the pharmacological changes in rabbit corpus cavernosum (CC) secondary to incubation with lysolecithin and hypercholesterolaemia. A daily egg yolk dietary supplement induced gross hypercholesterolaemia in our rabbits. Group A of test animals (n-12) was fed with the yolk content of single egg and group B (n-6), that from two eggs for eight weeks. Serum level estimation revealed a progressive elevation of cholesterol to 15 and 30 times respectively, in the two treated groups as compared to values in the control group (n-6). Early histological manifestations of atherosclerosis were perceived as fat cell lesions in the cavernosum of treated animals. In vitro pharmacological studies on CC strips from both groups of test animals demonstrated a profound accentuation of the contractile responses to noradrenaline and histamine and attenuation of relaxant response to acetylcholine. However, in contrast to single-egg treated group, which demonstrated a reduction in the relaxant response to electrical field stimulation (EFS), there was a marked and statistically significant potentiation of this nitrergic transmission, in the two-eggs group. Prior incubation of CC strips of normolipidaemic rabbits (n-7) with lysolecithin, reproduced similar exaggerated response to EFS. Therefore, from the results of our study, it is concluded that oxidised LDL or its major amphiphile lysolecithin, at some critical level or beyond, may be capable of reverting at least some of the adverse effects of hypercholesterolaemia on erectile function, through its mediating effect on nitrergic transmission.
引用
收藏
页码:159 / 165
页数:7
相关论文
共 50 条
  • [11] Effect of clinical pharmacist intervention on low-density lipoprotein cholesterol (LDL-C) outcomes in an ambulatory setting
    Guy-Alfandary, S
    Lavi, S
    Raz, M
    Triki, N
    VALUE IN HEALTH, 2005, 8 (03) : 271 - 271
  • [12] Comparison of low-density lipoprotein cholesterol (LDL-c) estimates by in-lab and point-of-care devices in the context of emerging LDL-c equations
    Hubler, Zita
    Roper, Stephen
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2024, 162 : S165 - S165
  • [13] Comparison of low-density lipoprotein cholesterol (LDL-c) estimates by in-lab and point-of-care devices in the context of emerging LDL-c equations
    Hubler, Z.
    Roper, S.
    CLINICAL CHEMISTRY, 2024, 70
  • [14] Zoledronic acid increases high-density lipoprotein cholesterol (HDL-C) and decreases low-density lipoprotein cholesterol (LDL-C) in multiple myeloma patients
    Gozzetti, A.
    Martini, G.
    Avanzati, A.
    Franci, B.
    Marchini, E.
    Nuti, R.
    Lauria, F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 149 - 149
  • [15] Effect of Lipoprotein(a) on Stroke Recurrence Attenuates at Low LDL-C (Low-Density Lipoprotein) and Inflammation Levels
    Xu, Jie
    Hao, Xiwa
    Zhan, Rui
    Jiang, Xue
    Jin, Aoming
    Xue, Jing
    Cheng, Aichun
    Liu, Jiewen
    Lin, Jinxi
    Meng, Xia
    Li, Hao
    Zheng, Lemin
    Wang, Yongjun
    STROKE, 2022, 53 (08) : 2504 - 2511
  • [16] The clinical impact of estimating low-density lipoprotein cholesterol (LDL-C) using different equations in the general population
    Lam, Reyna
    Manemann, Sheila M.
    Seehusen, Kristina E.
    Remaley, Alan T.
    Sauver, Jennifer L. St.
    Jiang, Ruoxiang
    Killian, Jill M.
    Sampson, Maureen
    Meeusen, Jeffrey W.
    Decker, Paul A.
    Roger, Veronique L.
    Takahashi, Paul Y.
    Larson, Nicholas B.
    Bielinski, Suzette J.
    LIPIDS IN HEALTH AND DISEASE, 2024, 23 (01)
  • [17] The Association Between Achieving Low-Density Lipoprotein Cholesterol (LDL-C) Goal and Statin Treatment in an Employee Population
    Burton, Wayne N.
    Chen, Chin-Yu
    Schultz, Alyssa B.
    Edington, Dee W.
    POPULATION HEALTH MANAGEMENT, 2010, 13 (01) : 1 - 8
  • [18] CHOLESTEROL FEEDING AND LOW-DENSITY LIPOPROTEIN (LDL) METABOLISM
    SLATER, HR
    MCKINNEY, L
    PACKARD, CJ
    LAWRIE, TDV
    MORGAN, HG
    SHEPHERD, J
    SCOTTISH MEDICAL JOURNAL, 1983, 28 (03) : 316 - 316
  • [19] Evaluation of low-density lipoprotein cholesterol (LDL-C) in HIV-infected men using the traditional Friedewald and the novel Martin-Hopkins LDL-C equations
    Schneider, E. E.
    Sarkar, S.
    Margolick, J.
    Martin, S. S.
    Post, W. S.
    Brown, T. T.
    ANTIVIRAL THERAPY, 2018, 23 : A52 - A52
  • [20] Review of cholesterol management and the impact of interventions on low-density lipoprotein cholesterol (LDL-C) goals as defined by the National Cholesterol Education Program (NCEP)
    Vanderbush, EJ
    Wong, SL
    ADVANCES IN CORONARY ARTERY DISEASE, 2001, : 357 - 361